Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Corcept Therapeutics Inc CORT

Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has... see more

Recent & Breaking News (NDAQ:CORT)

Corcept Shareholder Notice

Newsfile March 30, 2022

Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer

GlobeNewswire March 30, 2022

Corcept Shareholder Alert

Newsfile March 28, 2022

Corcept Investor Alert

Newsfile March 27, 2022

Corcept Update

Newsfile March 23, 2022

Corcept Shareholder Notice

Newsfile March 21, 2022

Corcept Shareholder Alert

Newsfile March 20, 2022

Corcept Investor Alert

Newsfile March 18, 2022

Corcept Shareholder Update

Newsfile March 16, 2022

Corcept Shareholder Notice

Newsfile March 15, 2022

Corcept Shareholder Alert

Newsfile March 14, 2022

Corcept Investor Alert

Newsfile March 13, 2022

Corcept Update

Newsfile March 11, 2022

Corcept Shareholder Notice

Newsfile March 9, 2022

Corcept Shareholder Alert

Newsfile March 8, 2022

Corcept Investor Alert

Newsfile March 7, 2022

Corcept Update

Newsfile March 6, 2022

Corcept Update

Newsfile March 4, 2022

Corcept Shareholder Notice

Newsfile March 1, 2022

Corcept Therapeutics to Host Ovarian Cancer Program Update on Thursday, March 31, 2022

GlobeNewswire March 1, 2022